PSORIASIS (PSO)
Clinical trials for PSORIASIS (PSO) explained in plain language.
Never miss a new study
Get alerted when new PSORIASIS (PSO) trials appear
Sign up with your email to follow new studies for PSORIASIS (PSO), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Psoriasis drug ESK-001 tested for Long-Term safety and effectiveness
Disease control OngoingThis study looks at the long-term safety and effectiveness of the drug ESK-001 in adults with moderate to severe plaque psoriasis. Participants must have completed a prior ESK-001 study. They will take ESK-001 twice daily for 24 weeks, then some may switch to a placebo to see if …
Matched conditions: PSORIASIS (PSO)
Phase: PHASE3 • Sponsor: Alumis Inc • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Liver and skin disease study pulled before start
Knowledge-focused TerminatedThis study was designed to see if a medication called guselkumab, already approved for psoriatic disease, could also improve fatty liver disease in people with both conditions. It planned to enroll adults with psoriatic arthritis who were overweight and had high liver fat. Howeve…
Matched conditions: PSORIASIS (PSO)
Sponsor: University of California, San Diego • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC
-
Doctor education aims to boost use of cheaper biologic drugs
Knowledge-focused OngoingThis study tests whether offering doctors one-on-one educational meetings about biosimilar medications leads them to prescribe more biosimilars instead of the original brand-name drugs. About 1,325 clinicians who prescribe adalimumab will be randomly offered either an in-person o…
Matched conditions: PSORIASIS (PSO)
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 07, 2026 18:39 UTC